We are happy to annouce that 3 additional sites beside CHU Brest could be initiated in April and May 2024. We wish the study teams at all four sites good luck for recruiting of trial participants!
https://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.png00mpelusohttps://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.pngmpeluso2024-05-30 09:01:002024-05-30 09:01:03Four sites open in France: CHU Brest, CHU Dijon, Hospital Edouard Herriot in Lyon and CHU St. Etienne.
https://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.png00mpelusohttps://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.pngmpeluso2024-03-22 13:35:562024-03-28 13:39:01Second site in France, the university hospital in St. Étienne, was initiated and will soon start with patient recruiting.
First patient recruited in Lyon (F)!
We are happy to announce that the CHU de Lyon in France enrolled the first study participant on 14th of June 2024. Congratulation to the study team!
Four sites open in France: CHU Brest, CHU Dijon, Hospital Edouard Herriot in Lyon and CHU St. Etienne.
We are happy to annouce that 3 additional sites beside CHU Brest could be initiated in April and May 2024. We wish the study teams at all four sites good luck for recruiting of trial participants!
Second site in France, the university hospital in St. Étienne, was initiated and will soon start with patient recruiting.
We wish the study team good luck!